Fourth Notice of Rejection of Certain Executory Contracts (Vyaire Medical, Doc 688)

Summary

The Debtors give a Fourth Notice of Rejection of Certain Executory Contracts (Doc 688, filed 10/28/24, Case No. 24-11217 (BLS)) under the Rejection Procedures Order [Docket No. 250]. The notice states that the Debtors determined, in the exercise of their business judgment, that each Contract set forth on Exhibit A is rejected effective as of the Rejection Date. Objections must be filed and served no later than November 11, 2024; a claim from a rejection must be filed by the later of the proof of claim deadline and thirty (30) days after entry of an order approving the rejection. Exhibit A, Schedule of Rejected Contracts, lists rejection counterparties, contract descriptions and the Rejection Date. The notice carries /s/ Patrick J. Reilley, dated October 28, 2024.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Date: 2024-07-11

Cite this document

“Fourth Notice of Rejection of Certain Executory Contracts (Vyaire Medical, Doc 688).” Original at ecf.deb.uscourts.gov, dated 2024-07-11. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/2024-07-11-microsoft-word-vyaire-fourth-contract-rejection-notice-48677544-1-doc/, SHA-256 b4ce9e4e1fbc27ee0669bf8a566af66ee82b44ac38a0494f8b411677530d4e11.

Full text

IN THE UNITED STATES BANKRUPTCY COURT
FOR THE DISTRICT OF DELAWARE
)
In re:
)
Chapter 11
)
VYAIRE MEDICAL, INC., et al.,1
)
Case No. 24-11217 (BLS)
)
Debtors.
)
(Jointly Administered)
)
)
Re: Docket No. 250
FOURTH NOTICE OF REJECTION OF CERTAIN EXECUTORY CONTRACTS
PARTIES RECEIVING THIS NOTICE SHOULD LOCATE THEIR NAMES AND
THEIR CONTRACTS OR LEASES ON EXHIBIT A ATTACHED HERETO AND READ
THE CONTENTS OF THIS NOTICE CAREFULLY.
PLEASE TAKE NOTICE that on July 11, 2024, the United States Bankruptcy Court
for the District of Delaware (the “Court”) entered an order on the motion (the “Motion”)
2 of
debtors and debtors in possession (the “Debtors”), approving procedures for the rejection of
executory contracts and unexpired leases and granting related relief [Docket No. 250]
(the “Rejection Procedures Order”).
PLEASE TAKE FURTHER NOTICE that, pursuant to the Rejection Procedures Order
and by this written notice (this “Rejection Notice”), the Debtors hereby notify you that they have
determined, in the exercise of their business judgment, that each Contract set forth on Exhibit A
attached hereto is hereby rejected effective as of the date set forth in Exhibit A (the “Rejection
Date”), or such other date as the Debtors and the counterparty or counterparties to any such
Contract agree.
PLEASE TAKE FURTHER NOTICE that parties objecting to a proposed rejection
must file and serve a written objection so that such objection is filed with this Court on the
docket of the Debtors’ chapter 11 cases no later than November 11, 2024 (the “Rejection
Objection Deadline”) and promptly serve such objection on the following parties (collectively,
the “Objection Service Parties”): (a) the Debtors, Vyaire Medical, Inc., 26125 North
Riverwoods
Boulevard,
Mettawa,
Illinois
60045,
Attn.:

Charles
Braley
1
The last four digits of Debtor Vyaire Medical, Inc.’s federal tax identification number are 6495. A complete list
of each of the Debtors in these chapter 11 cases and each such Debtor’s federal tax identification number may
be obtained on the website of the Debtors’ claims and noticing agent at https://omniagentsolutions.com/Vyaire.
The location of Debtor Vyaire Medical, Inc.’s principal place of business and the Debtors’ service address in
these chapter 11 cases is 26125 North Riverwoods Boulevard, Mettawa, Illinois, USA 60045.
2
Capitalized terms used but not otherwise defined herein have the meanings ascribed to them in the Motion.
Case 24-11217-BLS Doc 688 Filed 10/28/24 Page 1 of 15

2
(cbraley@alixpartners.com); (b) proposed co-counsel to the Debtors (i) Kirkland & Ellis LLP,
601 Lexington Avenue, New York, New York 10022, Attn.: Joshua A. Sussberg, P.C.
(joshua.sussberg@kirkland.com), Chris Ceresa (chris.ceresa@kirkland.com), and Tiffani
Chanroo (tiffani.chanroo@kirkland.com), and (ii) Kirkland & Ellis LLP, 333 Wolf Point Plaza,
Chicago, Illinois, 60654, Attn.: Spencer A. Winters (spencer.winters@kirkland.com) and Yusuf
U. Salloum (yusuf.salloum@kirkland.com); (c) proposed co-counsel to the Debtors (i) Cole
Schotz P.C., 500 Delaware Avenue, Suite 1410, Wilmington, Delaware 19801, Attn: Patrick J.
Reilley, Esq. (preilley@coleschotz.com), Stacy L. Newman (snewman@coleschotz.com),
Michael E. Fitzpatrick, Esq. (mfitzpatrick@coleschotz.com), and (ii) Cole Schotz P.C., Court
Plaza North, 25 Main Street, Hackensack, New Jersey 07601, Attn.: Michael D. Sirota, Esq.
(msirota@coleschotz.com), Warren A. Usatine, Esq. (wusatine@coleschotz.com); (d) counsel to
the 1L Ad Hoc Group, Gibson, Dunn & Crutcher LLP, 200 Park Avenue, New York, NY 10166-
0193, Attn.: Scott J. Greenberg (SGreenberg@gibsondunn.com), Jason Zachary Goldstein
(JGoldstein@gibsondunn.com), Joshua Brody (JBrody@gibsondunn.com), and Kevin Liang
(KLiang@gibsondunn.com); (e) counsel to the 1L Ad Hoc Group, Pachulski Stang Ziehl &
Jones LLP, 919 North Market Street, 17th Floor, Wilmington, DE 19801, Attn.: Laura Davis
Jones (ljones@pszjlaw.com) and Timothy P. Cairns (tcairns@pszjlaw.com); (f) the United States
Trustee
for
the
District
of
Delaware,
Attn.:
Benjamin
A.
Hackman
(Benjamin.A.Hackman@usdoj.gov); and (g) counsel to the Committee, (i) McDermott Will &
Emery
LLP,
The
Brandywine
Building,
1000
N.
West
Street, Suite
1400, Wilmington, Delaware 19801, Attn.: David Hurst (dhurst@mwe.com) and Maris
Kandestin (mkandestin@mwe.com) and (ii) McDermott Will & Emery LLP, One Vanderbilt
Avenue, New York, NY 10017-3852, Attn: Darren Azman (dazman@mwe.com) and Kristin
Going (kgoing@mwe.com). Only those responses that are timely filed, served, and received will
be considered at any hearing.
PLEASE TAKE FURTHER NOTICE that, absent an objection being timely filed, the
Debtors shall seek entry of the proposed form of order attached hereto as Exhibit B, and the
rejection of each Contract shall become effective on the Rejection Date set forth in Exhibit A, or
such other date as the Debtors and the counterparty or counterparties to such Contract agree.
3
PLEASE TAKE FURTHER NOTICE that, if an objection to the rejection of any
Contract is timely filed and not withdrawn or resolved, the Debtors shall file a notice for a
hearing to consider the objection for the Contract or Contracts to which such objection relates.
If such objection is overruled or withdrawn, such Contract or Contracts shall be rejected as of the
Rejection Date set forth in Exhibit A or such other date as the Debtors and the counterparty or
counterparties to any such Contract agree.
PLEASE TAKE FURTHER NOTICE that, pursuant to the terms of the Rejection
Procedures Order, if the Debtors have deposited monies with a Rejection Counterparty as a
3
An objection to the rejection of any particular Contract listed in this Rejection Notice shall not constitute an
objection to the rejection of any other contract or lease listed in this Rejection Notice. Any objection to the
rejection of any particular Contract listed in this Rejection Notice must state with specificity the Contract to
which it is directed. For each particular Contract whose rejection is not timely or properly objected to, such
rejection will be effective in accordance with this Rejection Notice and the Rejection Procedures Order.
Case 24-11217-BLS Doc 688 Filed 10/28/24 Page 2 of 15

3
security deposit or other arrangement, the Rejection Counterparty may not setoff or recoup or
otherwise use such monies without further order of the Court, unless the Debtors and the
counterparty or counterparties to such Contracts otherwise agree in writing.
PLEASE TAKE FURTHER NOTICE that, absent timely objection, any personal
property of the Debtors or any tangible goods that are listed and described in Exhibit A shall be
deemed abandoned as of the Rejection Date.
PLEASE TAKE FURTHER NOTICE that, to the extent you wish to assert a claim
with respect to the rejection of your Contract or Contracts, you must do so by the later of (a) the
applicable deadline for filing proofs of claim established in these chapter 11 cases and (b) thirty
(30) days after the entry of an order of the Court approving the rejection. IF YOU FAIL TO
TIMELY SUBMIT A PROOF OF CLAIM IN THE APPROPRIATE FORM BY THE
DEADLINE SET FORTH HEREIN, YOU WILL BE FOREVER BARRED, ESTOPPED,
AND ENJOINED FROM (1) ASSERTING SUCH CLAIM AGAINST ANY OF THE
DEBTORS AND THEIR CHAPTER 11 ESTATES, (2) VOTING ON ANY CHAPTER 11
PLAN FILED IN THESE CASES ON ACCOUNT OF SUCH CLAIM, AND
(3) PARTICIPATING IN ANY DISTRIBUTION IN THE DEBTORS’ CHAPTER 11
CASES ON ACCOUNT OF SUCH CLAIM.
[Remainder of page intentionally left blank]
Case 24-11217-BLS Doc 688 Filed 10/28/24 Page 3 of 15

Dated: October 28, 2024
Wilmington, Delaware
/s/ Patrick J. Reilley
COLE SCHOTZ P.C.
KIRKLAND & ELLIS LLP
Patrick J. Reilley (DE Bar No. 4451)
KIRKLAND & ELLIS INTERNATIONAL LLP
500 Delaware Avenue, Suite 1410
Joshua A. Sussberg, P.C. (admitted pro hac vice)
Wilmington, Delaware 19801
601 Lexington Ave
Telephone:
(302) 651-2001
New York, New York 10022
Facsimile:
(302) 652-3117
Telephone:
(212) 446-4800
Email:
preilley@coleschotz.com
Facsimile:
(212) 446-4900
Email:
joshua.sussberg@kirkland.com
- and -
- and -
Michael D. Sirota, Esq. (admitted pro hac vice)
Spencer A. Winters, P.C. (admitted pro hac vice)
Warren A. Usatine, Esq (admitted pro hac vice)
Yusuf U. Salloum (admitted pro hac vice)
Court Plaza North, 25 Main Street
333 West Wolf Point Plaza
Hackensack, New Jersey 07601
Chicago, Illinois 60654
Telephone:
(201) 489-3000
Telephone:
(312) 862-2000
Facsimile:
(201) 489-1536
Facsimile:
(312) 862-2200
Email:
msirota@coleschotz.com
Email:
spencer.winters@kirkland.com
wusatine@coleschotz.com
yusuf.salloum@kirkland.com
Co-Counsel to the Debtors
Co-Counsel to the Debtors
and Debtors in Possession
and Debtors in Possession
Case 24-11217-BLS Doc 688 Filed 10/28/24 Page 4 of 15

EXHIBIT A
Schedule of Rejected Contracts
Case 24-11217-BLS Doc 688 Filed 10/28/24 Page 5 of 15

Rejection Counterparty
Debtor Entity
Description of Contract1
Abandoned Personal
Property, if Applicable
Rejection Date (Effective
Date of Rejection)
1-800-Got-Junk Commercial Services
(USA) LLC
Vyaire Medical, Inc.
1-800-Got-Junk Commercial Services (USA), LLC 2019-11-15 CDA
N/A
10/28/2024
3-D Polymers
Vyaire Medical, Inc.
3-D Polymers 2021-03-11 CDA
N/A
10/28/2024
3D Systems GmbH
Vyaire Medical, Inc.
3D Systems GmbH 2021-02-05 CDA
N/A
10/28/2024
3D Systems GmbH
Vyaire Medical, Inc.
3D Systems GmbH 2020-08-10 CDA
N/A
10/28/2024
3D Systems GmbH
Vyaire Medical, Inc.
3D Systems GmbH 2020-08-28 CDA
N/A
10/28/2024
3KRF
Vyaire Medical, Inc.
3KRF 2019-02-22
N/A
10/28/2024
3M Company and 3M Innovative
Properties Company
Vyaire Medical, Inc.
3M Co. and 3M Innovative Properties Co. 2020-11-23 CDA
N/A
10/28/2024
A Plus International
Vyaire Medical, Inc.
A Plus International 2020-10-14 CDA
N/A
10/28/2024
A Uno Tec S.R.L.
Vyaire Medical, Inc.
A Uno Tec S.R.L. 2019-01-14 CDA
N/A
10/28/2024
A&G Ltd.
Vyaire Medical, Inc.
A&G Ltd. 2021-08-10 CDA
N/A
10/28/2024
AAA Cooper Transportation
Vyaire Medical, Inc.
AAA Cooper Transportation 2019-02-21 Vyaire CDA
N/A
10/28/2024
AC Aircontrols GmbH
Vyaire Medical, Inc.
AC Aircontrols GmbH 2021-03-22 CDA
N/A
10/28/2024
Acal Precision Products
Vyaire Medical, Inc.
Acal Precision Products LLC 2020-07-31 CDA
N/A
10/28/2024
Accelerant
Vyaire Medical, Inc.
Accelerant 2018-05-02 CDA
N/A
10/28/2024
Accelerant
Vyaire Medical, Inc.
Accelerant 2020-03-11 CDA
N/A
10/28/2024
Accent Plastics, Inc.
Vyaire Medical, Inc.
Accent Plastics, Inc. 2019-09-19 CDA
N/A
10/28/2024
Accent Plastics, Inc.
Vyaire Medical, Inc.
Accent Plastics, Inc. 2019-09-25 CDA
N/A
10/28/2024
Accenture LLP
Vyaire Medical, Inc.
Accenture LLP 2017-03-10 CDA
N/A
10/28/2024
AccuMED Corp.
Vyaire Medical, Inc.
AccuMED Corp. 2019-01-10 CDA
N/A
10/28/2024
AccuMED Corp.
Vyaire Medical, Inc.
AccuMED Corp. 2018-01-11 CDA
N/A
10/28/2024
Ace Mold (Shanghai) Company
Limited
Vyaire Medical, Inc.
Ace Mold (Shanghai Company Limited 2017-03-13 Mutual CDA
N/A
10/28/2024
Ace Plastics Company Ltd.
Vyaire Medical, Inc.
Ace Plastics Company Ltd. 2021-08-31 CDA
N/A
10/28/2024
Ace Plastics Technologies Ltd.
Vyaire Medical, Inc.
Ace Plastics Technologies Ltd. 2020-09-15 CDA
N/A
10/28/2024
Ace Plastics Technologies Ltdl
Vyaire Medical, Inc.
Ace Plastics Technologies Ltd. 2020-09-15 CDA
N/A
10/28/2024
Acertys Healthcare NV
Vyaire Medical, Inc.
Acertys Healthcare NV 2019-02-12 CDA
N/A
10/28/2024
Acertys Healthcare NV
Vyaire Medical, Inc.
Acertys Healthcare NV 2019-02-12 CDA
N/A
10/28/2024
Activar Industrial Products Group,
Inc. dba Springs, Inc.
Vyaire Medical, Inc.
Activar Industrial Products Group, Inc. 2019-03-27 CDA
N/A
10/28/2024
Aculon, Inc.
Vyaire Medical, Inc.
Aculon, Inc. 2017-02-15 CDA
N/A
10/28/2024
Acutronic
Vyaire Medical, Inc.
Acutronic 2017-06-20 Vyaire Mutual CDA.doc
N/A
10/28/2024
Ad Pack Industrial Supplies SA DE DV
Vyaire Medical, Inc.
Ad Pack Industrial Supplies SA DE CV 2021-08-11 CDA
N/A
10/28/2024
Advanced Inhalation Therapies (AIT),
Ltd
Vyaire Medical, Inc.
Advanced Inhalation Therapies, Ltd 2018-03-22 CDA
N/A
10/28/2024
Advanced Lifetime Respiratory
Services
Vyaire Medical, Inc.
Advanced Lifetime Respiratory Services 2018-02-07 CDA
N/A
10/28/2024
Advanced Medical Solutions Limited
Vyaire Medical, Inc.
Advanced medical Solutions Ltd. 2023-02-08 CDA
N/A
10/28/2024
Advanced Motion Controls
Vyaire Medical, Inc.
Advanced Motion Controls 2018-01-10 CDA
N/A
10/28/2024
Advanced Solutions Network LLC dba
Plastics Services Network
Vyaire Medical, Inc.
Advanced Solutions Network LLC dba Plastics Services Network
2020-11-04 CDA
N/A
10/28/2024
Advantech Corporation
Vyaire Medical, Inc.
Advantech Corporation 2019-12-13 CDA
N/A
10/28/2024
Aerogen Limited
Vyaire Medical, Inc.
Aerogen Limited_Vyaire Medical, Inc. CDA 2022.02.15
N/A
10/28/2024
Aerogen LTD
Vyaire Medical, Inc.
Aerogen LTD 2018-08-06 CDA.pdf
N/A
10/28/2024
Aerogen LTD
Vyaire Medical, Inc.
Aerogen LTD 2022-02-15 CDA
N/A
10/28/2024
Aerotek
Vyaire Medical, Inc.
Aerotek 2019-12-02 CDA
N/A
10/28/2024
Aerotek
Vyaire Medical, Inc.
Aerotek, Inc. 2016-10-03
N/A
10/28/2024
AES Molds Inc
Vyaire Medical, Inc.
AES Molds Inc 2020-02-03 CDA
N/A
10/28/2024
Afco Credit Corporation
Vyaire Medical, Inc.
Afco Credit Corporation 2019-03-11 CDA
N/A
10/28/2024
AG Industries
Vyaire Medical, Inc.
AG Industries, Filtration Group 2018-07-20 CDA.pdf
N/A
10/28/2024
AG Industries
Vyaire Medical, Inc.
AG Industries 2021-08-13 CDA
N/A
10/28/2024
AG Net Lease Acquisition Corp.
Vyaire Medical, Inc.
AG Net Lease Acquisition Corp. 2021-04-07 CDA
N/A
10/28/2024
Airgas USA, LLC
Vyaire Medical, Inc.
Airgas USA, LLC 2020-09-23 CDA
N/A
10/28/2024
Airways Freight Corp.
Vyaire Medical, Inc.
Airways Freight Corp.
N/A
10/28/2024
Aisin World Corp. of America
Vyaire Medical, Inc.
Aisin World Corp of America 2020-04-21 CDA
N/A
10/28/2024
Akeso & Company Limited
Vyaire Medical, Inc.
Akeso & Company Ltd. 2022-11-02 CDA
N/A
10/28/2024
AKM Anschluss, Kunststoff und
Montagetechnik GmbH
Vyaire Medical, Inc.
AKM Anschluss 2023-01-17 CDA
N/A
10/28/2024
Aleph One Limited
Vyaire Medical, Inc.
Aleph One Limited 2018-01-05 CDA
N/A
10/28/2024
Alexander Group, Inc.
Vyaire Medical, Inc.
Alexander Group, Inc. 2020-02-10 CDA
N/A
10/28/2024
Aleysian LLC
Vyaire Medical, Inc.
Aleysian LLC 2019-09-19 CDA
N/A
10/28/2024
Align Technology Inc.
Vyaire Medical, Inc.
Align Technology Inc. 2020-04-04 CDA
N/A
10/28/2024
All Flex Flexible Circuits LLC
Vyaire Medical, Inc.
All Flex Flexible Circuits LLC 2019-03-20 CDA
N/A
10/28/2024
All Sensors
Vyaire Medical, Inc.
All Sensors 2017-01-12 CDA
N/A
10/28/2024
Allianz Global Risk
Vyaire Medical, Inc.
Allianz Global Risks 2017-08-04 CDA
N/A
10/28/2024
Allied Electronics, Inc.
Vyaire Medical, Inc.
Allied Electronics Inc 2018-04-16 CDA
N/A
10/28/2024
Allied Healthcare Products
Vyaire Medical, Inc.
Allied Healthcare Products 2020-09-04 CDA
N/A
10/28/2024
Allplast GmbH
Vyaire Medical, Inc.
Allplast GmbH 2022-04-07 CDA
N/A
10/28/2024
ALT Technology
Vyaire Medical, Inc.
ALT Technology 2019-01-11 CDA
N/A
10/28/2024
Altaviz LLC
Vyaire Medical, Inc.
Altaviz LLC 2021-05-17 CDA
N/A
10/28/2024
Altaviz LLC
Vyaire Medical, Inc.
Altaviz and Medspray 2022-01-10 CDA
N/A
10/28/2024
Rejected Contracts
1 The inclusion of a Contract on this list does not constitute an admission as to the executory or non-executory nature of the Contract, or
as to the existence or validity of any claims held by the counterparty or counterparties to such Contract.
Case 24-11217-BLS Doc 688 Filed 10/28/24 Page 6 of 15

Rejection Counterparty
Debtor Entity
Description of Contract
Abandoned Personal
Property, if Applicable
Rejection Date (Effective
Date of Rejection)
Altran US Corp
Vyaire Medical, Inc.
Altran US Corp 2020-05-06 CDA
N/A
10/28/2024
Alumina Ceramic Components
Vyaire Medical, Inc.
Alumina Ceramic Components 2020-10-15 CDA
N/A
10/28/2024
Alvarez & Marsal Europe LLP
Vyaire Medical, Inc.
Alvarez & Marsal Europe LLP 2020-12-16 CDA
N/A
10/28/2024
A-M Systems
Vyaire Medical, Inc.
A-M Systems 2018-04-11 CDA.pdf
N/A
10/28/2024
AMA Plastics
Vyaire Medical, Inc.
AMA Plastics 2017-09-25 CDA
N/A
10/28/2024
AMA Plastics
Vyaire Medical, Inc.
AMA Plastics 2021-09-28 CDA
N/A
10/28/2024
Amazon.com, Inc.
Vyaire Medical, Inc.
Amazon.com, Inc. 2017-04-07 IT Mutual NDA
N/A
10/28/2024
Ambrit Engineering
Vyaire Medical, Inc.
Ambrit Engineering Corporation 2021-02-10 CDA
N/A
10/28/2024
Ambrit Engineering
Vyaire Medical, Inc.
Ambrit Engineering 2018-03-30 CDA.pdf
N/A
10/28/2024
Amcor PLC
Vyaire Medical, Inc.
Amcor PLC 2021-08-06 CDA
N/A
10/28/2024
Amcor PLC
Vyaire Medical, Inc.
Amcor Flexibles LLC 2019-10-23 CDA
N/A
10/28/2024
American Force Private Security Inc.
Vyaire Medical, Inc.
American Force Private Security Inc. 2021-03-26 CDA
N/A
10/28/2024
American Industrial Plastics, LLC dba
AIP Precision Machining
Vyaire Medical, Inc.
American Industrial Plastics 2020-05-21 CDA
N/A
10/28/2024
American Precision Industries, Inc.
(Portescap)
Vyaire Medical, Inc.
American Precision Industries, Inc. 2017-06-06 CDA
N/A
10/28/2024
American Precision Industries, Inc.
(Portescap)
Vyaire Medical, Inc.
American Precision Industries, Inc. (Portescap) 2020-04-06 CDA
N/A
10/28/2024
American West Analytical Labs
Vyaire Medical, Inc.
American West Analytical Labs 2019-03-04 CDA
N/A
10/28/2024
American West Analytical Labs
Vyaire Medical, Inc.
American West Analytical Labs 2021-03-04 CDA
N/A
10/28/2024
Americhem, Inc.
Vyaire Medical, Inc.
Americhem, Inc. 2021-02-16 CDA
N/A
10/28/2024
Ametek Technical & Industrial
Products
Vyaire Medical, Inc.
Ametek Technical & Industrial Products 2017-06-19 CDA
N/A
10/28/2024
Ametek Technical & Industrial
Products
Vyaire Medical, Inc.
Ametek Technical & Industrial Products 2021-04-08 CDA
N/A
10/28/2024
AMI US Holdings, Inc.
Vyaire Medical, Inc.
AMI US Holdings, Inc. 2021-01-31 CDA
N/A
10/28/2024
Amico Pateint Care Corporation
Vyaire Medical, Inc.
Amico Patient Care Corporation 2017-10-19 CDA
N/A
10/28/2024
Amphenol Thermometrics, Inc.
Vyaire Medical, Inc.
Amphenol Thermometrics, Inc. 2019-01-07 CDA
N/A
10/28/2024
Amsino
Vyaire Medical, Inc.
Amsino Medical Group 2018-08-08 CDA.pdf
N/A
10/28/2024
Amsino
Vyaire Medical, Inc.
Amsino 2021-08-13 CDA
N/A
10/28/2024
Analog Devices, Inc.
Vyaire Medical, Inc.
Analog Devices, Inc. 2017-09-08 NDA
N/A
10/28/2024
Analytical Industries
Vyaire Medical, Inc.
Analytical Industries, Inc. 2020-11-11 CDA
N/A
10/28/2024
Analytical Industries
Vyaire Medical, Inc.
Analytical Industries 2018-03-26 CDA
N/A
10/28/2024
Andercraft de Mexico NMH
Marketing LLC
Vyaire Medical, Inc.
Andercraft de Mexico NMH Marketing LLC 2017-11-29 CDA
N/A
10/28/2024
Andersen Tax LLC
Vyaire Medical, Inc.
Andersen Tax LLC 2018-11-09 CDA
N/A
10/28/2024
Anko Electronics Inc.
Vyaire Medical, Inc.
Anko Electronics 2020-10-15 CDA
N/A
10/28/2024
Anko Electronics Inc.
Vyaire Medical, Inc.
Anko Electronics Inc. 2018-01-08 CDA
N/A
10/28/2024
Antonio, Fanny (The Surgical
Company)
Vyaire Medical, Inc.
Antoni, Fanny (The Surgical Company) 2022-01-19 CDA
N/A
10/28/2024
AOK Tooling Limited
Vyaire Medical, Inc.
AOK Tooling Limited 2019-04-22 CDA
N/A
10/28/2024
Aon Consulting, Inc.
Vyaire Medical, Inc.
Aon Consulting, Inc. 2020-10-23 CDA
N/A
10/28/2024
SunMed Group Holdings, LLC
Vyaire Holding Company
TSA with SunMed 2023-05-01
N/A
10/28/2024
Case 24-11217-BLS Doc 688 Filed 10/28/24 Page 7 of 15

EXHIBIT B
Proposed Contract Rejection Order
Case 24-11217-BLS Doc 688 Filed 10/28/24 Page 8 of 15

IN THE UNITED STATES BANKRUPTCY COURT
FOR THE DISTRICT OF DELAWARE
)
In re:
)
Chapter 11
)
VYAIRE MEDICAL, INC., et al.,1
)
Case No. 24-11217 (BLS)
)
Debtors.
)
(Jointly Administered)
)
)
Re: Docket No. [●]
FOURTH ORDER AUTHORIZING
THE DEBTORS TO REJECT CERTAIN EXECUTORY CONTRACTS
Pursuant to and in accordance with the Order (I) Authorizing and Approving Procedures
to Reject Executory Contracts and Unexpired Leases and (II) Granting Related Relief [Docket
No. 250] (the “Rejection Procedures Order”)
2 entered in the chapter 11 cases of the above-
captioned debtors and debtors in possession (collectively, the “Debtors”); and it appearing that
the Fourth Notice of Rejection of Certain Executory Contracts [Docket No. [●]] (the “Rejection
Notice”) satisfies the requirements set forth in the Rejection Procedures Order; and the United
States District Court for the District of Delaware has jurisdiction over this matter pursuant to 28
U.S.C. § 1334, which was referred to the Court under 28 U.S.C. § 157 and the Amended
Standing Order of Reference from the United States District Court for the District of Delaware,
dated February 29, 2012; and this Court having found that this is a core proceeding pursuant to
28 U.S.C. § 157(b)(2); and this Court having found that this Court may enter a final order
consistent with Article III of the United States Constitution; and this Court having found that
1
The last four digits of Debtor Vyaire Medical, Inc.’s federal tax identification number are 6495. A complete list
of each of the Debtors in these chapter 11 cases and each such Debtor’s federal tax identification number may
be obtained on the website of the Debtors’ claims and noticing agent at https://omniagentsolutions.com/Vyaire.
The location of Debtor Vyaire Medical, Inc.’s principal place of business and the Debtors’ service address in
these chapter 11 cases is 26125 North Riverwoods Boulevard, Mettawa, Illinois, USA 60045.
2
Capitalized terms used but not otherwise defined herein have the meanings ascribed to them in the Rejection
Procedures Order.
Case 24-11217-BLS Doc 688 Filed 10/28/24 Page 9 of 15

2
venue of this proceeding and the Rejection Notice in this district is proper pursuant to 28 U.S.C.
§§ 1408 and 1409; and this Court having found that the relief requested in the Rejection Notice
is in the best interests of the Debtors’ estates, their creditors, and other parties in interest; and this
Court having found that the Debtors’ notice of the Rejection Notice and opportunity for a
hearing on the Rejection Notice were appropriate and no other notice need be provided; and this
Court having reviewed the Rejection Notice; and this Court having determined that the legal and
factual bases set forth in the Rejection Notice establish just cause for the relief granted herein;
and upon all of the proceedings had before this Court; and after due deliberation and sufficient
cause appearing therefor, it is HEREBY ORDERED THAT:
1.
The Contracts set forth in Exhibit 1 attached hereto are hereby rejected as of the
Rejection Date.
2.
Any and all property located on the Debtors’ leased premises on the Rejection
Date of the applicable lease of nonresidential real property, including any personal property or
any tangible goods, shall be deemed abandoned pursuant to section 554 of the Bankruptcy Code,
as is, effective as of the Rejection Date. The applicable Rejection Counterparty or counterparties
may, in their sole discretion and without further order of this Court, utilize and/or dispose of such
property and, to the extent applicable, the automatic stay is modified to allow such disposition;
provided that, to the extent requested by the Rejection Counterparty, the Debtors shall be
permitted to abandon the Abandoned Property to such Rejection Counterparty to facilitate such
party’s use or disposal of such Abandoned Property.
3.
If any affected Rejection Counterparty to a Contract asserts a claim against the
Debtors arising from the rejection of the Contract, the counterparty must file a proof of claim on
or before the later of (i) the applicable deadline for filing proofs of claim established in these
Case 24-11217-BLS Doc 688 Filed 10/28/24 Page 10 of 15

3
chapter 11 cases, and (ii) thirty (30) days after the entry of this Order. If no proof of claim is
timely filed, such claimant shall be forever barred from asserting a claim for damages arising
from the rejection and from participating in any distributions on such a claim that may be made
in connection with these chapter 11 cases.
4.
Nothing contained in the Rejection Notice or this order, and no action taken
pursuant to the relief requested or granted, is intended as or shall be construed or deemed to be:
(a) an admission as to the amount, validity or priority of, or basis for any claim against the
Debtors under the Bankruptcy Code or other applicable nonbankruptcy law; (b) a waiver of the
Debtors’ or any other party in interest’s right to dispute any claim on any grounds; (c) a promise
or requirement to pay any particular claim; (d) an implication, admission, or finding that any
particular claim is an administrative expense claim, other priority claim or otherwise of a type
specified or defined in the Rejection Notice or this order; (e) an admission as to the validity,
priority, enforceability, or perfection of any lien on, security interest in, or other encumbrance on
property of the Debtors’ estates; or (f) a waiver or limitation of any claims, causes of action, or
other rights of the Debtors or any other party in interest against any person or entity under the
Bankruptcy Code or any other applicable law.
5.
All rights and defenses of the Debtors are preserved, including all rights and
defenses of the Debtors with respect to a claim for damages arising as a result of a Contract
rejection, including any right to assert an offset, recoupment, counterclaim, or deduction.
In addition, nothing in this order or the Rejection Notice shall limit the Debtors’ ability to
subsequently assert that any particular Contract is terminated and is no longer an executory
contract or unexpired lease, respectively.
Case 24-11217-BLS Doc 688 Filed 10/28/24 Page 11 of 15

4
6.
Notice of the Rejection Notice as provided therein shall be deemed good and
sufficient notice of such Rejection Notice and the requirements of Bankruptcy Rule 6004(a) and
the Local Rules are satisfied by such notice.
7.
Notwithstanding Bankruptcy Rule 6004(h), the terms and conditions of this order
are immediately effective and enforceable upon its entry.
8.
The Debtors are authorized to take all actions necessary to effectuate the relief
granted in this order.
9.
This Court retains jurisdiction with respect to all matters arising from or related to
the implementation, interpretation, and enforcement of this order.
Case 24-11217-BLS Doc 688 Filed 10/28/24 Page 12 of 15

EXHIBIT 1
(Rejection Schedule)
Case 24-11217-BLS Doc 688 Filed 10/28/24 Page 13 of 15

File and source

File: gov.uscourts.deb.193283.688.0.pdf
Size: 410,450 bytes
SHA-256: b4ce9e4e1fbc27ee0669bf8a566af66ee82b44ac38a0494f8b411677530d4e11
Our copy: gov.uscourts.deb.193283.688.0.pdf
Original: PACER (login required)

Fourth Notice of Rejection of Certain Executory Contracts (Vyaire Medical, Doc 688)

Summary

Cite this document

Full text

File and source

Related records